NervGen Pharma (NGENF) Q3 2024 Earnings

Aug 22Confirmed
Aug 2022
Nov 2022
Q2 2024
Q3 2024
-0.14
-0.1
-0.07
-0.03

Details

Expected EPS
-0.065763
Actual EPS
-0.080377
Surprise EPS
-0.01
Surprise Percent
-22.22%

Description

⁨NervGen Pharma⁩ (⁦NGENF⁩) has reported earnings of ⁦-0.080377⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts